
CAS 1352879-65-2
:Formule :C27H27N3O2
InChI :InChI=1S/C27H27N3O2/c1-19-23(22-15-9-10-16-24(22)28-19)18-26(31)29-25(17-20-11-5-3-6-12-20)27(32)30(2)21-13-7-4-8-14-21/h3-16,25,28H,17-18H2,1-2H3,(H,29,31)/t25-/m0/s1
Code InChI :ACDFWSNAQWFRRF-VWLOTQADSA-N
SMILES :CC1=C(C2=CC=CC=C2N1)CC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N(C)C4=CC=CC=C4
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
PF-3450074
CAS :PF-3450074 (PF-74) is a specific HIV-1 inhibitor, blocking viral replication and uncoating at submicromolar EC50=8-640 nM.Formule :C27H27N3O2Degré de pureté :98.57%Couleur et forme :SolidMasse moléculaire :425.5222(S)-N-Methyl-2-(2-(2-Methyl-1H-Indol-3-Yl)Acetamido)-N,3-Diphenylpropanamide
CAS :(S)-N-Methyl-2-(2-(2-Methyl-1H-Indol-3-Yl)Acetamido)-N,3-DiphenylpropanamideFormule :C27H27N3O2Degré de pureté :≥98%Masse moléculaire :425.52(S)-N-Methyl-2-(2-(2-methyl-1H-indol-3-yl)acetamido)-N,3-diphenylpropanamide
CAS :Degré de pureté :99%(S)-N-Methyl-2-(2-(2-methyl-1H-indol-3-yl)acetamido)-N,3-diphenylpropanamide
CAS :(S)-N-Methyl-2-(2-(2-methyl-1H-indol-3-yl)acetamido)-N,3-diphenylpropanamideFormule :C27H27N3O2Degré de pureté :99%Masse moléculaire :425.52PF-3450074
CAS :PF-3450074 is a novel molecule that has been shown to inhibit the replication of wild-type HIV. It targets the HIV capsid and inhibits the assembly of new virus particles by binding to the cyclic peptide (CP) domain of the viral protein. PF-3450074 has also been shown to be active against other viruses, including herpes simplex virus type 1, influenza A virus, hepatitis C virus, and vesicular stomatitis virus. PF-3450074 is a potent anthelmintic drug that has been shown to inhibit larval development in nematodes. The molecule binds to huRNP K and interferes with macrophage activation by inhibiting NFκB transcriptional activity.Formule :C27H27N3O2Degré de pureté :Min. 95%Masse moléculaire :425.52 g/mol




